Stavebnice a spoločenské hry
Dátum zverejnenia: 12/03/2021
- Región: New York
- Mesto: New York
- PSČ: New York
- Adresa: TvcerLfwEZ
Aj tu môže byť vaša reklama.
US dollars http://dvd-shrink-software.de/procardia-baikal-pharmacycom-vyjg procardia baikal-pharmacy.com “We resume coverage of TRI with a Neutral rating and a $35 12-month EV/EBITDA-based target price due to 8% total return, largely in line with the 4% average upside for the group. TRI has been the worst performing stock under coverage the last three years (-42% vs. the S&P 500 since January 2011) as results for its Financial & Risk (F&R) division (54% of 2013E revenue) deteriorated. The decline was driven by lower spending by financial institution clients and loss of market share due to poor execution on a series of upgrades to its Eikon integrated desktops. YTD the stock is roughly flat vs. the S&P.,” the firm’s analyst wrote.
